Troglitazone suppresses cell growth of KU812 cells independently of PPARgamma.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  European Journal of Pharmacology

• Publication date

  2002-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0014-2999(01)01577-1PMID 11834241
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anticancer effects of thiazolidinediones are independent of peroxisome proliferator-activated receptor gamma and mediated by inhibition of translation initiation.

  2001cited by this paper
• Magnitude of Peroxisome Proliferator-Activated Receptor-γ Activation is Associated With Important and Seemingly Opposite Biological Responses in Breast Cancer Cells

  2001cited by this paper
• The effects of thiazolidinediones on vascular smooth muscle cell activation by angiotensin II.

  2000cited by this paper
• Roles of PPARs in health and disease

  2000cited by this paper
• Peroxisome Proliferator-activated Receptor γ Ligands Inhibit Retinoblastoma Phosphorylation and G1 → S Transition in Vascular Smooth Muscle Cells*

  2000cited by this paper
• Molecular Basis of Vitamin E Action

  2000cited by this paper
• The Nuclear Receptor PPARγ and Immunoregulation: PPARγ Mediates Inhibition of Helper T Cell Responses1

  2000cited by this paper
• Histamine Is a Potent Inducer of IL-18 and IFN-γ in Human Peripheral Blood Mononuclear Cells

  2000cited by this paper
• Histamine is a potent inducer of IL-18 and IFN-gamma in human peripheral blood mononuclear cells.

  2000cited by this paper
• Peroxisome proliferator-activated receptor gamma ligands inhibit retinoblastoma phosphorylation and G1--> S transition in vascular smooth muscle cells.

  2000cited by this paper
• Troglitazone induces expression of PPARgamma in liver.

  1999cited by this paper
• Vitamin E: function and metabolism

  1999cited by this paper
• Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma.

  1999cited by this paper
• Troglitazone Induces Expression of PPARγ in Liver

  1999cited by this paper
• PPARγ activators down‐regulate the expression of PPARγ in 3T3‐L1 adipocytes

  1999cited by this paper
• Growth inhibition of myeloid leukemia cells by troglitazone, a ligand for peroxisome proliferator activated receptor gamma, and retinoids.

  1999cited by this paper
• PPARgamma activators down-regulate the expression of PPARgamma in 3T3-L1 adipocytes.

  1999cited by this paper
• Troglitazone suppresses cell growth of myeloid leukemia cell lines by induction of p21WAF1/CIP1 cyclin-dependent kinase inhibitor.

  1999cited by this paper
• Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator-activated receptor gamma.

  1998cited by this paper
• PPAR-γ agonists inhibit production of monocyte inflammatory cytokines

  1998cited by this paper
• Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

  1998cited by this paper
• The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation

  1998cited by this paper
• Identification of High-Affinity Binding Sites for the Insulin Sensitizer Rosiglitazone (BRL-49653) in Rodent and Human Adipocytes Using a Radioiodinated Ligand for Peroxisomal Proliferator-Activated Receptor γ

  1998cited by this paper
• Effects of troglitazone on the growth and differentiation of hematopoietic cell lines.

  1998cited by this paper
• Mast Cell-/Basophil-specific Transcriptional Regulation of Human l-Histidine Decarboxylase Gene by CpG Methylation in the Promoter Region*

  1998cited by this paper
• Basophilic differentiation of the human leukemia cell line KU812 upon treatment with interleukin-4.

  1998cited by this paper
• PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines.

  1998cited by this paper
• Activation of Proliferator-activated Receptors α and γ Induces Apoptosis of Human Monocyte-derived Macrophages*

  1998cited by this paper
• The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation.

  1998cited by this paper
• Troglitazone has a scavenging effect on reactive oxygen species.

  1997cited by this paper
• Differential expression of proteins regulating cell cycle progression in growth vs. differentiation.

  1997cited by this paper
• Mechanisms of action of troglitazone in the prevention of high glucose-induced migration and proliferation of cultured coronary smooth muscle cells.

  1997cited by this paper
• An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma).

  1995cited by this paper
• An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ) (*)

  1995cited by this paper
• Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone.

  1994cited by this paper
• Inhibition of protein kinase C activity and vascular smooth muscle cell growth by d-alpha-tocopherol.

  1994cited by this paper
• Inhibition of protein kinase C activity and vascular smooth muscle cell growth by d-α-tocopherol

  1994cited by this paper
• Metabolic Effects of New Oral Hypoglycemic Agent CS-045 in NIDDM Subjects

  1992cited by this paper
• 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO.

  1991cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper

• Brown adipocytes promote epithelial mesenchymal transition of neuroblastoma cells by inducing PPAR-γ/UCP2 expression

  2022cites this paper
• PPARγ Agonists in Combination Cancer Therapies.

  2019cites this paper
• New thiazacridine agents: Synthesis, physical and chemical characterization, and in vitro anticancer evaluation

  2017cites this paper
• Role of Epidermal Growth Factor Receptor (EGFR)-Signaling Versus Cellular Acidosis Via

  2016cites this paper
• Anticancer Activities of Pterostilbene-Isothiocyanate Conjugate in Breast Cancer Cells: Involvement of PPARγ

  2014cites this paper
• Targeting PPARγ Signaling Cascade for the Prevention and Treatment of Prostate Cancer

  2012cites this paper
• The PPARγ Antagonist T0070907 Suppresses Breast Cancer Cell Proliferation and Motility via Both PPARγ-dependent and -independent Mechanisms

  2011cites this paper
• PPARγ Promotes Growth and Invasion of Thyroid Cancer Cells

  2011cites this paper
• MiR-27b targets PPARγ to inhibit growth, tumor progression, and the inflammatory response in neuroblastoma cells

  2011cites this paper
• The PPARgamma antagonist T0070907 suppresses breast cancer cell proliferation and motility via both PPARgamma-dependent and -independent mechanisms.

  2011cites this paper
• Lycium barbarum (Goji Berry) extracts and its taurine component inhibit PPAR-γ-dependent gene transcription in human retinal pigment epithelial cells: Possible implications for diabetic retinopathy treatment.

  2011cites this paper
• Anticancer activity of thymoquinone in breast cancer cells: possible involvement of PPAR-γ pathway.

  2011cites this paper
• Etude du facteur de transcription précoce EGR1 dans l'effet anti-prolifératif des ligands de PPARgamma sur les cellules cancéreuses mammaires

  2011cites this paper
• The PPARγ Antagonist T 0070907 Suppresses Breast Cancer Cell Proliferation and Motility via Both PPARγ-dependent and-independent Mechanisms

  2011cites this paper
• Breathing New Life into Old Drugs: Indication Discovery by Systems Directed Therapy

  2010cites this paper
• Cancer microenvironment and therapeutic implications

  2009cites this paper
• Pomegranate flower ameliorates fatty liver in an animal model of type 2 diabetes and obesity.

  2009cites this paper
• Activating peroxisome proliferator-activated receptor gamma mutant promotes tumor growth in vivo by enhancing angiogenesis.

  2009cites this paper
• Rosiglitazone reduces cell invasiveness by inducing MKP-1 in human U87MG glioma cells.

  2009cites this paper
• New synthetic derivatives of triterpenoids in the treatment of cancer

  2009cites this paper
• New Indications for Established Drugs Able to Modify Tumour-Host Interactions

  2009cites this paper
• Correlated expression of peroxisome proliferator‐activated receptor γ with high histologic grade and basal type in invasive ductal carcinoma of the breast

  2009cites this paper
• Effets des ligands de PPAR[gamma] sur la voie de signalisation des oestrogènes dans les cellules cancéreuses mammaires

  2009cites this paper
• Potential Benefits of Glitazones for Cancer and Vascular Disease

  2008cites this paper
• Increased renal collagen cross‐linking and lipid accumulation in nephropathy of Zucker diabetic fatty rats

  2008cites this paper
• Down-regulation of PPARgamma1 suppresses cell growth and induces apoptosis in MCF-7 breast cancer cells

  2008cites this paper
• Effects of 15-deoxy-Delta12, 14 prostaglandin J2 and ciglitazone on human cancer cell cycle progression and death: the role of PPARgamma.

  2008cites this paper
• Salacia oblonga root decreases cardiac hypertrophy in Zucker diabetic fatty rats: inhibition of cardiac expression of angiotensin II type 1 receptor

  2008cites this paper
• Antitumorale und antiangiogenetische Effekte von Biomodulatoren beim malignen Melanom und Angiosarkom

  2008cites this paper
• Effects of 15-deoxy-Δ12, 14 prostaglandin J2 and ciglitazone on human cancer cell cycle progression and death: The role of PPARγ

  2008cites this paper
• PPARγ in immunity and inflammation: cell types and diseases

  2007cites this paper
• PPAR-γ in the Cardiovascular System

  2007cites this paper
• New mechanism-based anticancer drugs that act as orphan nuclear receptor agonists

  2007cites this paper
• Gypenoside XLIX, a naturally occurring PPAR-alpha activator, inhibits cytokine-induced vascular cell adhesion molecule-1 expression and activity in human endothelial cells.

  2007cites this paper
• Novel PPAR‐gamma Agonists Identified from a Natural Product Library: A Virtual Screening, Induced‐Fit Docking and Biological Assay Study

  2007cites this paper
• Gypenoside XLIX, a naturally occurring gynosaponin, PPAR-alpha dependently inhibits LPS-induced tissue factor expression and activity in human THP-1 monocytic cells.

  2007cites this paper
• PPARgamma in immunity and inflammation: cell types and diseases.

  2007cites this paper
• Role of Epidermal Growth Factor Receptor (EGFR)-Signaling Versus Cellular Acidosis Via Na+/H+ Exchanger1(NHE1)-Inhibition in Troglitazone-Induced Growth Arrest of Breast Cancer-Derived Cells MCF-7

  2007cites this paper
• Thiazolidinedione anti-cancer activity: Is inhibition of microtubule assembly implicated?

  2007cites this paper
• Gypenoside XLIX isolated from Gynostemma pentaphyllum inhibits nuclear factor-kappaB activation via a PPAR-alpha-dependent pathway.

  2006cites this paper
• Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS)

  2006cites this paper
• Pioglitazone inhibits the growth of human leukemia cell lines and primary leukemia cells while sparing normal hematopoietic stem cells.

  2006cites this paper
• Harpagoside suppresses lipopolysaccharide-induced iNOS and COX-2 expression through inhibition of NF-kappa B activation.

  2006cites this paper
• Bromelain improves decrease in defecation in postoperative rats: modulation of colonic gene expression of inducible nitric oxide synthase.

  2006cites this paper
• The potential of antidiabetic thiazolidinediones for anticancer therapy

  2006cites this paper
• Salacia oblonga root improves postprandial hyperlipidemia and hepatic steatosis in Zucker diabetic fatty rats: activation of PPAR-alpha.

  2006cites this paper
• A novel LXR-alpha activator identified from the natural product Gynostemma pentaphyllum.

  2005cites this paper
• Pomegranate Flower Extract Diminishes Cardiac Fibrosis in Zucker Diabetic Fatty Rats: Modulation of Cardiac Endothelin-1 and Nuclear Factor-kappaB Pathways

  2005cites this paper
• Anti-diabetic action of Punica granatum flower extract: activation of PPAR-gamma and identification of an active component.

  2005cites this paper
• Antidiabetic thiazolidinediones induce ductal differentiation but not apoptosis in pancreatic cancer cells.

  2005cites this paper
• Peroxisome proliferator activated receptor-gamma ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells.

  2005cites this paper
• Peroxisome proliferator activated receptor-γ ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells

  2005cites this paper
• Pomegranate flower improves cardiac lipid metabolism in a diabetic rat model: role of lowering circulating lipids

  2005cites this paper
• Thiazolidinediones inhibit growth and invasiveness of the human adrenocortical cancer cell line H295R.

  2005cites this paper
• The peroxisome proliferator-activated receptor gamma ligand troglitazone induces apoptosis and p53 in rat granulosa cells.

  2005cites this paper
• Receptor-independent actions of PPAR thiazolidinedione agonists: is mitochondrial function the key?

  2005cites this paper
• A novel LXR-α activator identified from the natural product Gynostemma pentaphyllum

  2005cites this paper
• Cardiomyocyte-Specific Knockout and Agonist of Peroxisome Proliferator–Activated Receptor-γ Both Induce Cardiac Hypertrophy in Mice

  2005cites this paper
• Induce Cardiac Hypertrophy in Mice γ Receptor-Activated − Cardiomyocyte-Specific Knockout and Agonist of Peroxisome Proliferator

  2005cites this paper
• PPAR gamma signaling exacerbates mammary gland tumor development.

  2004cites this paper
• PPAR signaling exacerbates mammary gland tumor development

  2004cites this paper
• Antidiabetic thiazolidinediones inhibit invasiveness of pancreatic cancer cells via PPARγ independent mechanisms

  2004cites this paper
• Inhibition of cell proliferation by potential peroxisome proliferator-activated receptor (PPAR) gamma agonists and antagonists.

  2004cites this paper
• PPAR signaling exacerbates mammary gland tumor development

  2004cites this paper
• A novel PPAR alpha/gamma dual agonist inhibits cell growth and induces apoptosis in human glioblastoma T98G cells.

  2004cites this paper
• Troglitazone Acts on Cellular pH and DNA Synthesis through a Peroxisome Proliferator-Activated Receptor γ-Independent Mechanism in Breast Cancer-Derived Cell Lines

  2004cites this paper
• Selective activation of PPARγ inhibits pancreatic cancer invasion and decreases expression of tissue plasminogen activator

  2003cites this paper
• Peroxisome Proliferator-activated Receptor and Cancers 1

  2003cites this paper
• Peroxisome proliferator-activated receptor γ and cancers

  2003cites this paper
• Selective activation of PPARgamma inhibits pancreatic cancer invasion and decreases expression of tissue plasminogen activator.

  2003cites this paper
• Expression and Functional Role of Peroxisome Proliferator-Activated Receptor-γ in Ovarian Folliculogenesis in the Sheep1

  2003cites this paper
• Peroxisome proliferator-activated receptor gamma and cancers.

  2003cites this paper
• Peroxisome proliferator-activated receptor gamma ligands inhibit cell growth and induce apoptosis in human liver cancer BEL-7402 cells.

  2003cites this paper
• Peroxisome proliferator-activated receptor ligands negatively regulate the expression of the high-affinity IgE receptor Fc epsilon RI in human basophilic KU812 cells.

  2002cites this paper